adjuvant < adjuvanted < adjuvants

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by adjuvanted

Number of relevant bibliographic references: 105.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000364 (2019)	Fredrik Granath [Suède] ; Rolf Gedeborg [Suède] ; Hans Smedje [Suède] ; Nils Feltelius [Suède]	Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.
000536 (2018)	Li Song [République populaire de Chine] ; Dan Xiong [République populaire de Chine] ; Maozhi Hu [République populaire de Chine] ; Xinan Jiao [République populaire de Chine] ; Zhiming Pan [République populaire de Chine]	Enhanced Th1/Th2 mixed immune responses elicited by polyethyleneimine adjuvanted influenza A (H7N9) antigen HA1-2 in chickens.
000746 (2017)	Amanda L. Wilkins [Australie] ; Dmitri Kazmin [États-Unis] ; Giorgio Napolitani [Royaume-Uni] ; Elizabeth A. Clutterbuck [Royaume-Uni] ; Bali Pulendran [États-Unis] ; Claire-Anne Siegrist [Suisse] ; Andrew J. Pollard [Royaume-Uni]	AS03- and MF59-Adjuvanted Influenza Vaccines in Children
000748 (2017)	Kinnera E. Chada [États-Unis] ; Richard Forshee [États-Unis] ; Hana Golding [États-Unis] ; Steven Anderson [États-Unis] ; Hong Yang [États-Unis]	A systematic review and meta-analysis of cross-reactivity of antibodies induced by oil-in-water emulsion adjuvanted influenza H5N1 virus monovalent vaccines.
000B55 (2015)	Olivier Godeaux [Belgique] ; Patricia Izurieta [Belgique] ; Miguel Madariaga [États-Unis] ; Mamadou Dramé [États-Unis] ; Ping Li [États-Unis] ; David W. Vaughn [Belgique]	Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 years.
000B56 (2015)	Timo Vesikari [États-Unis] ; Jan Hendrik Richardus ; Johan Berglund ; Tiina Korhonen ; Carl-Erik Flodmark ; Ann Lindstrand ; Sven Arne Silfverdal ; Vinod Bambure ; Adrian Caplanusi ; Ilse Dieussaert ; Sumita Roy-Ghanta ; David W. Vaughn	Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.
000C15 (2015)	Karen K. Yam [Canada] ; Jyotsana Gupta [Canada] ; Kaitlin Winter [Canada] ; Elizabeth Allen [Canada] ; Angela Brewer [Canada] ; Édith Beaulieu [Canada] ; Corey P. Mallett [Canada] ; David S. Burt [Canada] ; Brian J. Ward [Canada]	AS03-Adjuvanted, Very-Low-Dose Influenza Vaccines Induce Distinctive Immune Responses Compared to Unadjuvanted High-Dose Vaccines in BALB/c Mice
000C45 (2015)	Lawrence Segal [Belgique] ; Sandrine Wouters [Belgique] ; Danielle Morelle [Belgique] ; Gaëlle Gautier [France] ; Julien Le Gal [France] ; Thomas Martin [Royaume-Uni] ; Frieke Kuper [Pays-Bas] ; Eric Destexhe [Belgique] ; Arnaud M. Didierlaurent [Belgique] ; Nathalie Garçon [Belgique]	Non‐clinical safety and biodistribution of AS03‐adjuvanted inactivated pandemic influenza vaccines
000C56 (2015)	M. Fernández-Ruiz [Espagne] ; C. Lumbreras [Espagne] ; M. P. Arrazola [Espagne] ; F. L Pez-Medrano [Espagne] ; A. Andrés [Espagne] ; J. M. Morales [Espagne] ; J. R. De Juanes [Espagne] ; J. M. Aguado [Espagne]	Impact of squalene‐based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients
000C57 (2015)	A. Ambati [Suède] ; S. Einarsdottir [Suède] ; I. Magalhaes [Suède] ; T. Poiret [Suède] ; R. Bodenstein [Suède] ; K. Leblanc [Suède] ; M. Brune [Suède] ; M. Maeurer [Suède] ; P. Ljungman [Suède]	Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients
000F88 (2014)	Loes De Vries [Pays-Bas] ; Florence Van Hunsel [Pays-Bas] ; Benedikte Cuppers-Maarschalkerweerd [Pays-Bas] ; Eugène Van Puijenbroek [Pays-Bas] ; Kees Van Grootheest [Pays-Bas]	Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: Description of a prospective cohort and spontaneously reported pregnancy‐related adverse reactions in the Netherlands
001013 (2014)	Chia-Ying Wu [Taïwan] ; Ching-Yuan Chang [Taïwan] ; Hsiu-Hua Ma [Taïwan] ; Chiung-Wen Wang [Taïwan] ; Yung-Tsung Chen [Taïwan] ; Pei-Wen Hsiao [Taïwan] ; Ching-Chuan Chang [Taïwan] ; Chi-Hsien Chan [Taïwan] ; Chung-Cheng Liu [Taïwan] ; Juine-Ruey Chen [Taïwan]	Squalene-adjuvanted H7N9 virus vaccine induces robust humoral immune response against H7N9 and H7N7 viruses
001027 (2014)	Isabelle Rouleau [Canada] ; Gaston De Serres [Canada] ; Danuta M. Skowronski [Canada] ; Jean Philippe Drolet [Canada] ; Chantal Lemired [Canada] ; Eveline Toth [Canada] ; Monique Landry [Canada]	Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada
001030 (2014)	Terry Nolan [Australie] ; Sumita Roy-Ghanta [États-Unis] ; May Montellano [Philippines] ; Lily Weckx [Brésil] ; Rolando Ulloa-Gutierrez [Costa Rica] ; Eduardo Lazcano-Ponce [Mexique] ; Angkool Kerdpanich [Thaïlande] ; Marco Aurélio Palazzi Safadi [Brésil] ; Aurelio Cruz-Valdez [Mexique] ; Sandra Litao [Philippines] ; FONG SENG LIM [Singapour] ; Abiel Mascare As De Los Santos [Mexique] ; Miguel Angel Rodriguez Weber [Mexique] ; Juan-Carlos Tinoco [Mexique] ; Marcela Hernandez-De Mezerville [Costa Rica] ; Idis Faingezicht [Costa Rica] ; Pensri Kosuwon [Thaïlande] ; Pio Lopez [Colombie] ; Charissa Borja-Tabora [Philippines] ; PING LI [États-Unis] ; Serge Durviaux [Belgique] ; Louis Fries [États-Unis] ; Gary Dubin [États-Unis] ; Thomas Breuer [Belgique] ; Bruce L. Innis [États-Unis] ; David W. Vaughn [Belgique]	Relative Efficacy of AS03-Adjuvanted Pandemic Influenza A(H1N1) Vaccine in Children: Results of a Controlled, Randomized Efficacy Trial
001116 (2014)	Nathalie Dhedin [France] ; Anne Krivine [France] ; Nicole Le Corre [France] ; Alain Mallet [France] ; Bruno Lioure [France] ; Jacques-Olivier Bay [France] ; Marie-Thérèse Rubio [France] ; Philippe Agape [Réunion] ; Anne Thiebaut [France] ; Jérôme Le Goff [France] ; Brigitte Autran [France] ; Patricia Ribaud [France]	Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients
001129 (2014)	Airi Poder [Estonie] ; Pavol Simurka [Slovaquie] ; PING LI [États-Unis] ; Sumita Roy-Ghanta [États-Unis] ; David Vaughn [États-Unis]	An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age
001158 (2013-09-16)	Odile Launay [France] ; Xavier Duval [France] ; Serge Fitoussi [France] ; Wolfgang Jilg [Allemagne] ; Angkool Kerdpanich [Thaïlande] ; May Montellano [Philippines] ; Tino Schwarz [Allemagne] ; Veerachai Watanveerade [Thaïlande] ; Jürgen Wenzel [Allemagne] ; Gerard Zalcman [France] ; Vinod Bambure [Inde] ; Ping Li [États-Unis] ; Adrian Caplanusi [Belgique] ; Anuradha Madan [États-Unis] ; Paul Gillard [Belgique] ; David Vaughn [États-Unis]	Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.
001222 (2013)	Karen K. Yam ; Jyotsana Gupta ; Angela Brewer ; David W. Scheifele ; Scott Halperin ; Brian J. Ward	Unusual Patterns of IgG Avidity in Some Young Children following Two Doses of the Adjuvanted Pandemic H1N1 (2009) Influenza Virus Vaccine
001819 (2013)	Isabelle Rouleau [Canada] ; Gaston De Serres [Canada] ; Jean Philippe Drolet [Canada] ; Danuta M. Skowronski [Canada] ; Manale Ouakki [Canada] ; Eveline Toth [Canada] ; Monique Landry [Canada] ; Suzanne Menard [Canada] ; Rémi Gagnon [Canada]	Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1 pdm09) vaccine
001962 (2012)	Xavier Duval [France] ; Adrian Caplanusi [Belgique] ; Henri Laurichesse [France] ; Dominique Deplanque [France] ; Pierre Loulergue [France] ; Tejaswini Vaman [Inde] ; Odile Launay [France] ; Paul Gillard [Belgique]	Flexibility of interval between vaccinations with AS03A-adjuvanted influenza A (H1N1) 2009 vaccine in adults aged 18-60 and >60 years: a randomized trial.
001A25 (2012)	Timo Vesikari [Finlande] ; Aino Forstén ; Karl-Heinz Herbinger ; Giovanni Della Cioppa ; Jenny Beygo ; Astrid Borkowski ; Nicola Groth ; Mariaviviana Bennati ; Frank Von Sonnenburg	Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "adjuvanted" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "adjuvanted" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    adjuvanted
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021